2026 EGM Results: Approval of Interim Dividend and Share Buyback Plan
-
Extraordinary general meeting held (2026-05-13, record date 2026-04-21)
-
Articles amendment (interim dividend clause) passed with 97.8% approval
-
Share buyback plan passed with 97.4% approval
-
Articles amendment for executive compensation regulation passed with 81.3% approval
-
Executive compensation regulation passed with 64.9% approval (excluding special interest shareholders)
KOSDAQ Filing Information
-
Filing: Result of Extraordinary General Meeting of Shareholders
-
Company: METABIOMED (059210)
-
Submission: METABIOMED.CO.,LTD
-
Receipt: 05-13-2026
-
Under KRX KOSDAQ Market Division